148 related articles for article (PubMed ID: 15274363)
41. Importance of age as a prognostic factor for tonsillar carcinoma.
Nguyen NP; Ly BH; Betz M; Vinh-Hung V
Ann Surg Oncol; 2010 Oct; 17(10):2570-7. PubMed ID: 20559738
[TBL] [Abstract][Full Text] [Related]
42. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer.
Hammarstedt L; Lindquist D; Dahlstrand H; Romanitan M; Dahlgren LO; Joneberg J; Creson N; Lindholm J; Ye W; Dalianis T; Munck-Wikland E
Int J Cancer; 2006 Dec; 119(11):2620-3. PubMed ID: 16991119
[TBL] [Abstract][Full Text] [Related]
43. Aetiological parallel between tonsillar and anogenital squamous-cell carcinomas.
Frisch M; Biggar RJ
Lancet; 1999 Oct; 354(9188):1442-3. PubMed ID: 10543674
[TBL] [Abstract][Full Text] [Related]
44. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
Hansson BG; Rosenquist K; Antonsson A; Wennerberg J; Schildt EB; Bladström A; Andersson G
Acta Otolaryngol; 2005 Dec; 125(12):1337-44. PubMed ID: 16303684
[TBL] [Abstract][Full Text] [Related]
45. Consensus-degenerate hybrid oligonucleotide primers (CODEHOP) for the detection of novel papillomaviruses and their application to esophageal and tonsillar carcinomas.
Baines JE; McGovern RM; Persing D; Gostout BS
J Virol Methods; 2005 Jan; 123(1):81-7. PubMed ID: 15582702
[TBL] [Abstract][Full Text] [Related]
46. Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada.
Pintos J; Black MJ; Sadeghi N; Ghadirian P; Zeitouni AG; Viscidi RP; Herrero R; Coutlée F; Franco EL
Oral Oncol; 2008 Mar; 44(3):242-50. PubMed ID: 17467327
[TBL] [Abstract][Full Text] [Related]
47. Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients.
Hoffmann M; Görögh T; Gottschlich S; Lohrey C; Rittgen W; Ambrosch P; Schwarz E; Kahn T
Cancer Lett; 2005 Feb; 218(2):199-206. PubMed ID: 15670897
[TBL] [Abstract][Full Text] [Related]
48. [Tonsillar and oral cancer should be considered in the discussion on HPV vaccine].
Andersson G; Hasson BG; Rosenquist K; Schildt EB; Wennerberg J
Lakartidningen; 2007 Jan 24-30; 104(4):257-8; author reply 258-9. PubMed ID: 17328475
[No Abstract] [Full Text] [Related]
49. Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic experience.
Liang XH; Lewis J; Foote R; Smith D; Kademani D
J Oral Maxillofac Surg; 2008 Sep; 66(9):1875-80. PubMed ID: 18718395
[TBL] [Abstract][Full Text] [Related]
50. HPV infections and tonsillar carcinoma.
Syrjänen S
J Clin Pathol; 2004 May; 57(5):449-55. PubMed ID: 15113849
[TBL] [Abstract][Full Text] [Related]
51. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
Rosenquist K
Swed Dent J Suppl; 2005; (179):1-66. PubMed ID: 16335030
[TBL] [Abstract][Full Text] [Related]
52. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM
Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value of human papillomavirus in the survival of head and neck cancer patients: an overview of the evidence.
Schlecht NF
Oncol Rep; 2005 Nov; 14(5):1239-47. PubMed ID: 16211291
[TBL] [Abstract][Full Text] [Related]
54. Human papilloma virus in hyperplastic tonsillar and adenoid tissues in children.
Mammas IN; Sourvinos G; Michael C; Spandidos DA
Pediatr Infect Dis J; 2006 Dec; 25(12):1158-62. PubMed ID: 17133162
[TBL] [Abstract][Full Text] [Related]
55. ["Epidemic" increase of tonsillar and base of tongue cancer. Explanation: parallel increase of HPV infections].
Munck-Wikland E; Attner P; Näsman A; Hammerstedt L; Ramqvist T; Dalianis T
Lakartidningen; 2010 Jun 30-Jul 20; 107(26-28):1702-4. PubMed ID: 20701150
[No Abstract] [Full Text] [Related]
56. Survival outcome of tonsillar squamous cell carcinoma (TSCC) in the context of human papillomavirus (HPV): A systematic review and meta-analysis.
Ahmadi N; Chan M; Huo YR; Sritharan N; Chin RY
Surgeon; 2019 Feb; 17(1):6-14. PubMed ID: 29843958
[TBL] [Abstract][Full Text] [Related]
57. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003.
Ryerson AB; Peters ES; Coughlin SS; Chen VW; Gillison ML; Reichman ME; Wu X; Chaturvedi AK; Kawaoka K
Cancer; 2008 Nov; 113(10 Suppl):2901-9. PubMed ID: 18980273
[TBL] [Abstract][Full Text] [Related]
58. PD-L1 expression in tonsillar cancer is associated with human papillomavirus positivity and improved survival: implications for anti-PD1 clinical trials.
Hong AM; Vilain RE; Romanes S; Yang J; Smith E; Jones D; Scolyer RA; Lee CS; Zhang M; Rose B
Oncotarget; 2016 Nov; 7(47):77010-77020. PubMed ID: 27776338
[TBL] [Abstract][Full Text] [Related]
59. Human papillomaviruses in lymph node neck metastases of head and neck cancers.
Hoffmann M; Gottschlich S; Görögh T; Lohrey C; Schwarz E; Ambrosch P; Kahn T
Acta Otolaryngol; 2005 Apr; 125(4):415-21. PubMed ID: 15823814
[TBL] [Abstract][Full Text] [Related]
60. Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery.
Lai CH; Chang CJ; Huang HJ; Hsueh S; Chao A; Yang JE; Lin CT; Huang SL; Hong JH; Chou HH; Wu TI; Huang KG; Wang CC; Chang TC
J Clin Oncol; 2007 Aug; 25(24):3628-34. PubMed ID: 17704412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
